Known under the brand name Lyxumia, scientists believe it may have a protective effect on the brain, helping to slow damage caused by the disease. The study involved 156 people who had been ...
The drug, originally developed by Zealand Pharma, has been available for several years in Europe under the brand name Lyxumia, but Sanofi has opted to market it as Adlyxin in the US. Adlyxin is ...